Filing Details
- Accession Number:
- 0001582945-20-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-10 16:05:03
- Reporting Period:
- 2019-12-12
- Accepted Time:
- 2020-03-10 16:05:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1425627 | Transbiotec Inc. | IMLE | Periodicals: Publishing Or Publishing & Printing (2721) | 260731818 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1794353 | John Gary Graham | 6400 S. Fiddlers Green Circle Suite 525 Greenwood Village CO 80111 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-12 | 0 | $0.00 | 0 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-02-15 | 0 | $0.00 | 0 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Convertible Preferred Stock | Acquisiton | 2019-12-12 | 1,000,000 | $1,000,000.00 | 1,000,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,000,000 | 2019-12-12 | 2029-12-22 | No | 4 | P | Indirect |
Footnotes
- On December 12, 2019, the Reporting Person received irrevocable proxies from five (5) shareholders of the Issuer for an aggregate of 112,908,180 shares of the Issuer's common stock equaling approximately 52.6% of the Issuer's outstanding voting rights. The proxies are for the limited purpose of approving all transactions related to the Asset Purchase Agreement entered into by and between the Issuer and IDTEC dated May 6, 2019, as amended. As a result of receiving these proxies the Reporting Person may be deemed to beneficially own, pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Act"), in excess of 10% of the outstanding common stock of the Issuer. The Reporting Person disclaims beneficial ownership of these shares for the purposes of Section 16 of the Act and the filing of this Form 4 shall not be an admission that the Reporting Person is the beneficial owner of such shares.
- On February 15, 2020, the Reporting Person received an additional irrevocable proxy from one of the same shareholders for an aggregate of 24,353,116 additional shares of the Issuer's common stock in accordance with the same terms and disclaimer set forth in footnote (1) above.
- The Issuer's 8% Series A-1 Convertible Preferred Stock is convertible into shares of the Issuer's common stock at the rate of $1 per share (which is the per share purchase price the Reporting Person paid for the 8% Series A-1 Convertible Preferred Stock).
- The shares of 8% Series A-1 Convertible Preferred Stock do not expire.
Billionaire Hedge Funds
